Literature DB >> 10215263

Pharmacology of coronary artery bypass grafts.

F L Rosenfeldt1, G W He, B F Buxton, J A Angus.   

Abstract

Spasm of arterial and venous graft conduits can occur both during harvesting and after the graft is connected. Attempts to overcome spasm during harvesting by probing or hydraulic distension can cause structural damage to the graft, which may impair short- and long-term patency. After a coronary artery bypass graft is connected, spasm can cause major problems with myocardial perfusion. To select the best pharmacologic agent to prevent or reverse vasoconstriction in a graft requires an understanding of the reactivity of that particular type of graft to vasoconstrictor and vasodilator agents. The pharmacologic reactivity of venous and arterial graft conduits has been documented through extensive studies of isolated vessels in the organ bath and of in situ grafts in the body. In this review we summarize the current state of knowledge of the reactivity of arterial and venous grafts to vasoconstrictor and vasodilator agents and describe the practical application of this knowledge in the operating room and in the postoperative period.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215263     DOI: 10.1016/s0003-4975(98)01299-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

1.  Midterm results of complete arterial revascularization in more than 1,000 patients using an internal thoracic artery/radial artery T graft.

Authors:  H B Barner; T M Sundt; M Bailey; Y Zang
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

2.  Arterial grafts: clinical classification and pharmacological management.

Authors:  Guo-Wei He
Journal:  Ann Cardiothorac Surg       Date:  2013-07

Review 3.  Thirty-year experience with bilateral internal thoracic artery grafting: where have we been and where are we going?

Authors:  Paul Kurlansky
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

4.  Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery.

Authors:  T J Batchelor; J R Sadaba; A Ishola; P Pacaud; C M Munsch; D J Beech
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  The sources of calcium for noradrenaline-induced contraction in the human thoracic internal artery.

Authors:  Leszek Buzun; Beata Modzelewska; Anna Kostrzewska; Ewa Kleszczewska; Tomasz Kleszczewski
Journal:  Pflugers Arch       Date:  2017-04-22       Impact factor: 3.657

Review 6.  Coronary vein graft disease: pathogenesis and prevention.

Authors:  Pirouz Parang; Rohit Arora
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

7.  Effect of Cymbopogon citratus and Citral on Vascular Smooth Muscle of the Isolated Thoracic Rat Aorta.

Authors:  R Chitra Devi; S M Sim; R Ismail
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-22       Impact factor: 2.629

8.  Potassium induced contraction of the internal thoracic artery in vitro is time related: the potential consequences in the analysis of the mechanism of the spasm after coronary artery bypass grafting and in the analysis of the results of in vitro studies.

Authors:  Tomasz Kleszczewski; Leszek Buzun; Anna Lisowska; Beata Modzelewska
Journal:  Heart Vessels       Date:  2015-05-05       Impact factor: 2.037

Review 9.  Insights into the pathogenesis of vein graft disease: lessons from intravascular ultrasound.

Authors:  Gavin J Murphy; Gianni D Angelini
Journal:  Cardiovasc Ultrasound       Date:  2004-07-21       Impact factor: 2.062

10.  Papaverine Prevents Vasospasm by Regulation of Myosin Light Chain Phosphorylation and Actin Polymerization in Human Saphenous Vein.

Authors:  Kyle M Hocking; Gowthami Putumbaka; Eric S Wise; Joyce Cheung-Flynn; Colleen M Brophy; Padmini Komalavilas
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.